<?xml version="1.0" encoding="UTF-8"?>
<ref id="B67">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Watanabe</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rathore</surname>
    <given-names>A. P.</given-names>
   </name>
   <name>
    <surname>Sung</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Khoo</surname>
    <given-names>Y. M.</given-names>
   </name>
   <name>
    <surname>Connolly</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2012</year>). 
  <article-title>Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.</article-title>
  <source>
   <italic>Antivir. Res.</italic>
  </source>
  <volume>96</volume>
  <fpage>32</fpage>â€“
  <lpage>35</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2012.07.008</pub-id>
  <?supplied-pmid 22867971?>
  <pub-id pub-id-type="pmid">22867971</pub-id>
 </mixed-citation>
</ref>
